Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma

Detalles Bibliográficos
Autores principales: Cho, Min-Seok, Kim, Jae Yong, Jung, Seung-Yeon, Ahn, Seo-Yeon, Song, Ga young, Yang, Deok-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234245/
https://www.ncbi.nlm.nih.gov/pubmed/28090494
http://dx.doi.org/10.5045/br.2016.51.4.285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234245/
https://www.ncbi.nlm.nih.gov/pubmed/28090494
http://dx.doi.org/10.5045/br.2016.51.4.285

Ejemplares similares